Castor raised $45 million in Series B funding led Eight Roads Ventures and F-Prime Capital.

Castor, an Amsterdam, The Netherlands and Hoboken, N.J., USA-based health-tech developer of clinical trial technology that automates the research process, announced closing series B funding at $45 million.

The money was raised from investors led by Eight Roads Ventures and F-Prime Capital, joined by Two Sigma Ventures and Inkef Capital.

Castor, founded in 2011 by CEO Derk Arts, developed a cloud-based medical research data platform intended to facilitate electronic data capture for medical research.

Castor previously raised $12 million in 2020 and $6.3 million in 2018.